wellrank.ai
Sign In
Vivelle-Dot logo

Vivelle-Dot

First cited by AI Jun 11, 2026
vivelle-dot.com

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

BHRT, daily share of AI answers mentioning Vivelle-Dot, through Jul 27, 2026.

16.7%

Avg position when mentioned: 3.3 · peak 29% on Jun 26

By engine

Where Vivelle-Dot is strong, and where it is invisible.

  • ChatGPT
    33.3%
  • Google AI
    20.0%
  • Claude
    13.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 114 positive mentions
  • 80 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Vivelle-Dot

ChatGPTJul 27, 2026, 09:44 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Short answer: Maybe — but it depends. "Bioidentical" hormones that are chemically identical to the hormones your body makes (for example 17β‑estradiol and micronized progesterone) can be effective and have similar safety profiles to conventional hormone therapy when you use FDA‑approved products under medical supervision. Custom‑made (compounded) BHRT carries extra unknown risks and is not routinely recommended by major medical societies. Key points doctors and professional organizations emphasize Definition: “Bioidentical” simply means the molecule matches human hormones (e.g., estradiol, progesterone). The label “natural” or “safer” is a marketing term, not a scientific guarantee. FDA‑approved vs compounded: FDA‑approved bioidentical products (tablets, patches, gels, vaginal rings) have standardized dosing, manufacturing oversight, and clinical testing. Compounded custom BHRT (made by compounding pharmacies) is not FDA‑approved, may have variable potency/contamination, and lacks the same safety/efficacy data. The FDA, ACOG, Endocrine Society and The North American Menopause Society (NAMS) warn against unproven claims about compounded BHRT. Benefits: Systemic hormone therapy (bioidentical or conventional) is the most effective treatment for menopausal vasomotor symptoms (hot flashes) and helps with vaginal atrophy. Local (vaginal) low‑dose estrogen helps urogenital symptoms with minimal systemic exposure. Risks: Hormone therapy carries potential risks — increased risk of blood clots, stroke, and, depending on the type and duration, a small increased breast cancer risk with combined estrogen + progestogen therapy. Many risks depend on age, medical history, hormone type, dose, route (oral vs transdermal), and how long you use it. Route matters: Transdermal estradiol (patch or gel) generally has a lower risk of blood clots than standard oral estrogens. Micronized progesterone may have a different risk profile than some synthetic progestins. Testing: Routine saliva hormone testing (often marketed by compounding pharmacies) is not reliable for guiding therapy. Blood tests sometimes used but clinical symptoms and risk factors usually guide decisions. Use principle: Most experts recommend using the lowest effective dose for the shortest duration needed, with individualized discussion of benefits and risks. What doctors typically recommend in practice Prefer FDA‑approved, bioidentical hormone products when possible because they are standardized and studied. Use transdermal estradiol if you have higher VTE risk factors. Consider vaginal low‑dose estrogen for isolated vaginal symptoms. Avoid systemic estrogen in patients with active or recent breast cancer, uncontrolled VTE, or some other contraindications. Be cautious about compounded BHRT and only consider it if an FDA‑approved formulation truly cannot meet a medical need; if used, pick an accredited compounding pharmacy and require certificates of analysis. Practical, actionable advice If you’re considering BHRT, discuss it with a clinician experienced in menopause care (a gynecologist, menopause specialist, or endocrinologist). Ask about the specific hormone, dose, route, expected benefits, and individualized risks (family history of breast cancer, clotting disorders, heart disease, stroke). Ask why a compounded product is being recommended instead of an FDA‑approved product. If a compounded product is used, ask for potency testing and proof that the compounding pharmacy follows USP standards or is accredited. Expect baseline evaluations (medical history, family history, possibly blood pressure, lipid/glucose checks and appropriate cancer screening) and periodic follow‑up. Specific FDA‑approved examples doctors commonly use Estradiol patches: Vivelle‑Dot, Climara — transdermal options with more steady delivery and lower clot risk than oral estrogen. Oral estradiol: Estrace (estradiol tablets). Micronized progesterone: Prometrium — a bioidentical progesterone available in FDA‑approved capsules. Vaginal/local estrogen: Vagifem (vaginal tablets) or estradiol vaginal rings/creams for local urogenital symptoms with minimal systemic exposure. If you want independent guidance Look for clinicians listed by The North American Menopause Society (NAMS) or consult your gynecologist/primary care doctor for a menopause-focused visit. Beware clinics that promise hormone pellets, saliva testing, or lifelong “customized” hormone regimens with claims of no risk. Bottom line Bioidentical hormones can be safe and effective when you use FDA‑approved preparations under a clinician’s supervision and after a careful review of risks and benefits. Be cautious about compounded BHRT — many doctors and professional societies advise against routine use because of variable quality and lack of evidence. If you’re considering BHRT, talk to a qualified clinician who can personalize therapy and monitor you appropriately.

Mentioned in position 1 of 5

Read full answer with sources →
ClaudeJul 27, 2026, 09:44 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Bioidentical Hormone Replacement Therapy (BHRT): What You Should Know What Doctors Generally Say Medical opinion is mixed but evolving: Mainstream Medical Organizations (like the Endocrine Society and FDA) note that: "Bioidentical" is largely a marketing term, not a strict medical classification FDA-approved bioidentical options exist and have safety data Custom-compounded versions lack rigorous testing Many doctors acknowledge BHRT can be appropriate for managing menopause symptoms, hormonal imbalances, and andropause when properly prescribed. Reputable Options to Consider Bijuva, Bijuve - FDA-approved estradiol/progesterone combination Prometrium - FDA-approved bioidentical progesterone Vivelle-Dot - FDA-approved bioidentical estradiol patch Wisp, Midi, Alloy - telehealth platforms with licensed hormone specialists Key Safety Considerations FDA-approved bioidentical hormones have established safety profiles Custom compounded versions from compounding pharmacies have less oversight Risks vary by age, health history, and dosage Pellet therapy specifically has less evidence behind it Strong Recommendation Consult a board-certified endocrinologist or menopause specialist (find one at menopause.org) rather than general wellness clinics, which sometimes oversell BHRT. Would you like more specific guidance on any aspect?

Mentioned in position 4 of 7

Read full answer with sources →
Google AIJul 27, 2026, 09:44 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Bioidentical Hormone Replacement Therapy (BHRT) is a topic with varying perspectives among medical professionals. While many doctors acknowledge its potential benefits for managing menopausal symptoms and other hormone deficiencies, there's also a degree of caution and ongoing research surrounding its safety and efficacy. Here's a breakdown of what doctors generally say and some brands that are often associated with BHRT: What Doctors Say About Bioidentical Hormones: Personalized Approach: A significant advantage of BHRT, as highlighted by many physicians, is its potential for customization. Bioidentical hormones are structurally identical to the hormones produced by the human body (estrogen, progesterone, testosterone). This allows for precise dosing and a tailored approach to address an individual's specific needs and hormone levels. Symptom Relief: Doctors often agree that BHRT can be very effective in relieving common menopausal symptoms such as hot flashes, night sweats, vaginal dryness, mood swings, and sleep disturbances. For some individuals, these benefits can significantly improve quality of life. Evolving Research and Guidelines: The medical community is still actively researching BHRT. While some studies have shown positive outcomes, long-term safety data is continually being gathered. Professional organizations like the North American Menopause Society (NAMS) and the American College of Obstetricians and Gynecologists (ACOG) provide guidelines for hormone therapy, which often include bioidentical options but emphasize a thorough risk-benefit assessment for each patient. They generally recommend the lowest effective dose for the shortest necessary duration. Potential Risks: Like any hormone therapy, BHRT is not without potential risks. These can include an increased risk of blood clots, stroke, heart attack, and certain cancers (breast, uterine), although the absolute risk is generally considered low, especially when properly managed and individualized. Doctors emphasize that these risks are often dependent on factors like age, medical history, dosage, and duration of treatment. "Bioidentical" vs. "FDA-Approved": It's important to note that while many bioidentical hormones are available in FDA-approved formulations (like those produced by major pharmaceutical companies), some compounded bioidentical hormone preparations may not have undergone the same rigorous FDA approval process for safety and efficacy. Doctors often prefer FDA-approved preparations when available due to their standardized quality control. Importance of a Qualified Practitioner: The consensus among doctors is that BHRT should only be prescribed and monitored by a qualified healthcare professional, such as a gynecologist, endocrinologist, or a physician specializing in hormone therapy. Self-treating or using unregulated products is strongly discouraged. They will perform necessary tests, discuss individual risk factors, and monitor progress closely. Brands and Services Associated with BHRT: When discussing BHRT, doctors often refer to specific types of hormones and sometimes brands that produce FDA-approved versions of these bioidentical hormones. It's crucial to understand that while a brand might produce a bioidentical hormone, the actual therapy is tailored by your doctor. Estradiol: This is the primary form of estrogen in women. Many pharmaceutical companies produce FDA-approved estradiol products, including: Estrace (brand name): Available in oral tablets, vaginal cream, and vaginal inserts. Estraderm, Vivelle-Dot, Alora (brand names): These are transdermal patch options that deliver estradiol through the skin. Femring, Estring (brand names): These are vaginal rings that release estradiol. Progesterone: This hormone is essential for balancing estrogen's effects and is crucial for women with a uterus to prevent endometrial hyperplasia. Prometrium (brand name): An FDA-approved micronized progesterone capsule that can be taken orally or vaginally. Testosterone: While often associated with men, testosterone is also important for women's energy, libido, and muscle mass. AndroGel, Testim, Fortesta (brand names): These are typically prescription testosterone gels for men but are sometimes used off-label in carefully controlled doses for women. Compounded Testosterone: Some physicians may prescribe compounded testosterone in creams or other forms for women, often at lower doses than men would use. Compounding Pharmacies: While not a specific brand, compounding pharmacies play a significant role in BHRT. These pharmacies can create custom hormone preparations based on a doctor's prescription, allowing for precise tailoring of dosages and combinations of hormones. Examples of compounding pharmacies include ScriptDerm or local independent compounding pharmacies. It's essential to ensure your doctor works with a reputable compounding pharmacy that adheres to strict quality control standards. In Summary: BHRT can be a safe and effective option for many individuals experiencing hormone deficiencies, particularly menopausal symptoms, when prescribed and managed by a qualified healthcare professional. Doctors generally view it favorably for its personalized approach and potential for symptom relief. However, they also emphasize the importance of a thorough risk-benefit analysis, using FDA-approved products when possible, and ongoing monitoring. The "safety" of BHRT is highly dependent on individualized treatment plans and the expertise of the prescribing physician.

Mentioned in position 5 of 13

Read full answer with sources →
ChatGPTJul 27, 2026, 09:43 UTC
How much does BHRT cost per month and does insurance ever cover it?

Short answer Typical out-of-pocket BHRT costs vary a lot: roughly $30–$300 per month for pills/creams/patches, $50–$500+/month for transdermal gels/brand-name products, and $100–$700+ per month equivalent for pellet therapy or injections (pellet insertions are usually $500–$2,000 per procedure that lasts several months). Insurance sometimes covers hormone therapy — more often for FDA‑approved products (generic estradiol, testosterone prescriptions, patches, injections) and when prescribed for a documented medical need — but many compounded “custom” bioidentical formulations and some pellet programs are paid out‑of‑pocket. Coverage rules vary widely by plan. What determines cost Type of product: generic estradiol tablets are inexpensive; brand patches/gels (AndroGel, Vivelle‑Dot, Climara) cost more; compounded creams/pellets cost differently. Source: pharmacy retail vs. compounding pharmacy vs. clinic pellet insertion. Dose and frequency. Extra costs: initial and follow‑up clinic visits, lab testing (hormone panels, liver/other labs), and insertion procedures for pellets. Your insurance plan (Medicare, Medicare Part D, employer plan, Medicaid) and whether prior authorization is required. Typical price examples (US, approximate) Generic oral estradiol: $4–$40/month. Estradiol patches (FDA brands like Vivelle‑Dot, Climara): $30–$250/month depending on brand and pharmacy. Compounded estradiol/testosterone creams: $40–$300/month. Testosterone gels (brand AndroGel, Testim): $200–$500+/month without coverage; generics are cheaper ($50–$200). Testosterone injections (generic testosterone cypionate): $20–$150/month depending on dose and frequency. Hormone pellets (BioTE-style pellets or other pellet programs): $500–$2,000 per insertion; insertions often every 3–6 months, so equivalent ~$100–$700+/month. Labs and doctor visits: initial visit $100–$300+, labs $50–$400 depending on tests and location. Insurance: what’s typical More likely covered: FDA‑approved hormone therapies when the prescriber documents medical necessity (e.g., menopausal symptoms, hypogonadism). Many employer plans and Medicare Part D will cover prescription estradiol/testosterone formulations after copay or coinsurance. Less likely covered: most compounded BHRT creams/lozenges/creams labeled “custom bioidentical” and many pellet insertion programs — insurers often classify these as not covered or cosmetic/experimental. Do this: check your plan’s drug formulary and medical benefit rules, ask your prescribing clinician to submit a diagnosis and prior authorization if needed, and ask the pharmacy to price both the branded and generic alternatives. Practical tips to lower cost Ask for a generic FDA‑approved alternative when clinically appropriate. Use GoodRx, singleCare, or pharmacy discount cards to compare retail prices. Compare retail vs. mail‑order pharmacies for maintenance meds. Ask your clinician to document medical necessity and pursue prior authorization if needed. Shop reputable compounding pharmacies only if your clinician specifically requires a compounded product. Specific brands/services (examples and why) Vivelle‑Dot or Climara (estradiol patches): FDA‑approved, consistent dosing and more likely to be covered by insurance than custom creams. Estrace (estradiol tablets/generic estradiol): inexpensive generic option for many patients. AndroGel, Testim, Axiron (testosterone gels) or generic testosterone cypionate injections: FDA‑regulated dosing and product consistency; coverage varies but often easier to get covered than compounded gels. BioTE (pellet program) and BodyLogicMD or Defy Medical (clinics that offer BHRT): widely known clinics/brands that offer standardized pellet programs or BHRT plans — useful if you prefer one‑stop care, but these programs often charge out‑of‑pocket. Wedgewood or Empower Pharmacy (reputable compounding pharmacies): if your clinician prescribes a compounded formulation, use a reputable national compounding pharmacy to ensure quality. If you want a closer estimate Tell me: Are you asking for male or female BHRT? Which delivery form are you considering (pills, patch, gel, pellet, injection)? Do you have a specific insurance type (private employer plan, Medicare, Medicaid, or uninsured)? I can give a more tailored cost range and check likely coverage scenarios.

Mentioned in position 2 of 13

Read full answer with sources →
ChatGPTJul 27, 2026, 09:43 UTC
BHRT pellets vs creams vs patches: which is best and who offers them?

Short answer: there’s no single “best” — pellets, creams, and patches all work but differ in how steady the hormones are, how easy they are to adjust, safety/side‑effect profiles, cost and who supplies them. Which is best for you depends on your symptoms, medical history (clotting, breast cancer, liver disease, etc.), need for dose flexibility, and tolerance for procedures. Quick comparison Pellets Pros: give steady, long‑acting hormone levels (3–6 months), one insertion procedure every few months so you don’t worry about daily dosing. Cons: minor in‑office surgical insertion and removal, harder to rapidly adjust dose if side effects occur, small infection/expulsion risk, most pellets are compounded (not FDA‑approved for women). Who offers them: pellet therapy is commonly provided through dedicated pellet programs/clinics such as BioTE Medical and SottoPelle and through many hormone clinics and compounding pharmacies that work with clinicians (also offered by some BodyLogicMD providers). If you choose pellets, use a clinician experienced in insertion and a reputable compounding pharmacy. Creams (topical gels/creams) Pros: easy to apply, dose is adjustable by changing amount used, many compounded bioidentical options available. Cons: absorption is highly variable between people, skin transfer to partners/children is possible, compounded preparations can vary in potency and quality; monitoring is important. Who offers them: prescription FDA products include Estrace (estradiol) cream; many practitioners use compounded bioidentical creams made by compounding pharmacies such as Wedgewood Pharmacy, Empower Pharmacy, Belmar Pharmacy, etc. Look for PCAB‑accreditation. Patches (transdermal) Pros: provide steady, predictable delivery for many patients; several FDA‑approved estradiol patches are available; easy to use and usually covered by insurance. Cons: possible skin irritation, need to replace regularly (every few days), limited brand/strength choices vs compounding. Who offers them: widely available prescription brands — Vivelle‑Dot (estradiol), Climara, Alora, Minivelle — are manufactured, FDA‑approved products prescribed by OB/GYNs or primary care. Testosterone patches (e.g., Androderm) are available for men. Practical points and safety “Bioidentical” means the hormones chemically match human hormones, but compounded BHRT is not FDA‑regulated in the same way as commercial products; quality can vary. FDA‑approved patches/creams have manufacturing oversight. Pellets are convenient but less flexible; creams are flexible but variable; patches are a middle ground with predictable delivery. Always check medical suitability first — estrogen (any form) may be contraindicated with certain histories (breast cancer, clotting disorders, some liver disease). If you pursue compounded products, use an accredited compounding pharmacy (look for PCAB certification) and a clinician experienced in BHRT. Make sure there is a plan for baseline labs and follow‑up monitoring. If you want, tell me: whether you’re seeking estrogen, progesterone, testosterone or a combination, any relevant medical history, and I can suggest which option is likely best for you and help find local clinics or telemedicine providers that specialize in BHRT.

Mentioned in position 8 of 12

Read full answer with sources →
ClaudeJul 27, 2026, 09:43 UTC
BHRT pellets vs creams vs patches: which is best and who offers them?

BHRT Delivery Methods: A Practical Comparison Pellets Best for: Consistent, hands-off hormone delivery (lasts 3-6 months) Pros: Steady hormone levels, no daily maintenance Cons: Can't easily adjust dose once inserted, minor procedure required Who offers them: BioTE Medical – largest pellet network, thousands of certified providers nationwide EvexiPEL – another major pellet training network SottoPelle – well-established pellet protocol Creams/Gels Best for: Flexible dosing, easy adjustments Pros: Easy to titrate, compounded to your needs Cons: Transfer risk to partners/children, absorption varies Who offers them: Compounding pharmacies like Belmar Pharmacy or Women's International Pharmacy Winona (telehealth, women-focused) Biote providers also prescribe compounded creams Patches Best for: Consistent delivery without procedures Pros: Steady absorption, FDA-approved options available, no transfer risk Cons: Skin irritation, need changing 1-2x weekly Who offers them: Vivelle-Dot (estradiol, widely prescribed) Climara – popular weekly patch Most gynecologists and Midi Health or Gennev telehealth platforms Quick Recommendation Want convenience? → Pellets (BioTE) Want flexibility? → Creams (Winona/compounding pharmacy) Want FDA-approved simplicity? → Patches (Vivelle-Dot through your doctor) Always work with a qualified provider to monitor levels through bloodwork.

Mentioned in position 7 of 10

Read full answer with sources →

TL;DR

Vivelle-Dot is a transdermal estradiol patch indicated for menopausal symptom relief, manufactured by Novartis and distributed under prescription in the United States. It appears at vivelle-dot.com and is currently ranked fifth in the Menopause and women's health category and sixth in BHRT on the WellRank AI-visibility index, with 22% and 20% visibility respectively. Across 158 tracked AI mentions, 97 are positive and none are mixed or cautious, signaling strong organic favorability in AI-generated answers about hormone therapy.

Company Overview

Vivelle-Dot is a prescription hormone therapy brand whose patch delivers estradiol transdermally, bypassing first-pass liver metabolism. The product is manufactured by Novartis; the brand is marketed and distributed in the United States under prescription guidelines. Its business model is pharmaceutical: revenue flows through insurer-covered and cash-pay prescriptions written by physicians, gynecologists, and women's health specialists.

Product Features

  • Twice-weekly transdermal estradiol patch in multiple dose strengths
  • Matrix-style adhesive design intended to be smaller than earlier patch generations
  • Delivers estrogen systemically for relief of vasomotor menopausal symptoms
  • Can be applied to the lower abdomen or buttocks for flexible placement
  • Available by prescription in several dose levels to allow titration

Target Market

Vivelle-Dot serves women experiencing moderate to severe menopausal symptoms, primarily hot flashes and night sweats, as well as those managing hypoestrogenism or osteoporosis prevention under physician guidance. Its primary market is the United States, where it is distributed through licensed pharmacies as a prescription product. It is relevant to perimenopausal and postmenopausal women who prefer a non-oral hormone delivery route, as discussed in sources such as this University of Colorado coverage of hormone delivery options.

Buyer Personas

  • A perimenopausal woman in her late forties whose gynecologist has recommended transdermal estrogen to manage frequent hot flashes and disrupted sleep.
  • A postmenopausal woman with a history of elevated triglycerides who prefers a patch over oral estrogen to avoid hepatic first-pass effects.
  • A women's health patient already familiar with BHRT options who has read comparisons like pellet versus patch analyses and is weighing convenience and dosing consistency.
  • A patient transitioning from a compounded estrogen cream or pellet therapy seeking an FDA-approved, standardized-dose alternative.

Funding & Performance

Vivelle-Dot is a branded prescription pharmaceutical product of Novartis, a publicly traded global pharmaceutical company. Revenue and sales figures specific to the Vivelle-Dot product line are not publicly disclosed as a standalone figure.

Recent Developments

Generic transdermal estradiol patches have entered the market over time, increasing competition for branded options like Vivelle-Dot, though the brand retains physician recognition. Growing clinical and media attention to the mental health dimensions of hormone therapy choice, as noted in research highlighted by the Menopause Society, has kept transdermal options like Vivelle-Dot prominent in clinical conversations. No specific recent product launches or reformulations are widely confirmed in public sources at this time.

Competitive Landscape

In WellRank's co-mention data, Vivelle-Dot appears alongside Climara, Divigel, and EstroGel as competing transdermal estrogen options, and shares AI answer space with oral and vaginal products including Estrace, Premarin, and Vagifem. Progestogen products Prometrium and Provera frequently co-appear because they are prescribed alongside estrogen therapy. Comparative resources such as this patch versus pellet overview from NAPGO and Hone Health's estradiol patch versus pill analysis are among the sources AI engines cite when discussing Vivelle-Dot in a competitive context.

Vivelle-Dot vs the brands AI recommends alongside it

The real competitive set in BHRT: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Vivelle-Dot logo
Vivelle-DotThis brand
#8
16.7%
Climara logo
Climara

161 shared answers

#14
11.7%
Estrace logo
Estrace

144 shared answers

#15
11.7%
Prometrium logo
Prometrium

142 shared answers

#12
11.7%
Premarin logo
Premarin

82 shared answers

#58
3.3%

Email me when overtakes Vivelle-Dot

One email the day the ranks flip. Nothing else.

User Sentiment

Of 158 AI-engine mentions tracked by WellRank, 97 are positive, 61 are neutral, and zero are mixed or cautious, which is an unusually clean sentiment profile for a prescription hormone therapy product. AI engines tend to describe Vivelle-Dot in factual, clinical terms when comparing delivery methods, contributing to its neutral mentions, while positive mentions reflect patient-reported convenience and symptom relief. No notable pattern of adverse or cautionary AI framing appears in the current corpus.

Pricing

As a prescription pharmaceutical, out-of-pocket cost for Vivelle-Dot varies widely depending on insurance coverage, pharmacy, and whether a patient uses a manufacturer savings program. Exact retail or copay figures are not published in a stable, universally applicable form and should be confirmed with a pharmacy or insurer.

Sources cited around Vivelle-Dot

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Vivelle-Dot weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Vivelle-Dot? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.